| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Commercial | SVP Commercial
1 company
McCourt Marion is an EVP Commercial at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $8.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $759.89 | $835,879.00 | -5.0% | -5.4% | +25.4% | |
| Feb 7, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $769.04 | $769,040.00 | -4.3% | -2.3% | +21.9% | |
| Feb 1, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $752.19 | $827,409.00 | -4.7% | +5.3% | +26.4% | |
| Jan 3, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $721.86 | $794,046.00 | -4.7% | +14.7% | +27.4% | |
| Dec 12, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sell | 264 | $730.17 | $192,764.88 | -1.4% | +1.3% | +16.3% | |
| Dec 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $756.19 | $831,809.00 | -5.3% | +1.2% | +7.0% | |
| Nov 4, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,000 | $727.82 | $727,820.00 | -4.8% | +1.5% | +10.4% | |
| Nov 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $750.00 | $825,000.00 | -5.3% | -3.1% | +4.1% | |
| Oct 3, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $705.39 | $775,929.00 | -2.7% | -2.0% | +10.0% | |
| Sep 1, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Commercial | Sale+OE | 1,100 | $577.62 | $635,382.00 | -5.3% | +25.2% | +38.5% |